Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
4.82 x 1524 4.94 x 2
Post-market by (Cboe BZX)
4.84 -0.01 (-0.21%) 04/17/25 [NASDAQ]
4.82 x 1524 4.94 x 2
Post-market 4.84 unch (unch) 16:49 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.82
Day High
4.96
Open 4.87
Previous Close 4.85 4.85
Volume 822,700 822,700
Avg Vol 821,810 821,810
Stochastic %K 80.45% 80.45%
Weighted Alpha -5.85 -5.85
5-Day Change +0.66 (+15.79%) +0.66 (+15.79%)
52-Week Range 3.05 - 8.17 3.05 - 8.17
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 236,192
  • Shares Outstanding, K 48,800
  • Annual Sales, $ 0 K
  • Annual Income, $ -63,730 K
  • EBIT $ -64 M
  • EBITDA $ -61 M
  • 60-Month Beta 1.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.79

Options Overview Details

View History
  • Implied Volatility 222.27% ( -16.29%)
  • Historical Volatility 66.10%
  • IV Percentile 90%
  • IV Rank 64.64%
  • IV High 334.35% on 02/20/25
  • IV Low 17.40% on 09/06/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 194
  • Volume Avg (30-Day) 427
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 8,907
  • Open Int (30-Day) 5,380

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.35
  • Number of Estimates 5
  • High Estimate -0.30
  • Low Estimate -0.39
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +33.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.93 +23.16%
on 04/09/25
Period Open: 5.30
5.41 -10.54%
on 03/20/25
-0.46 (-8.68%)
since 03/17/25
3-Month
3.93 +23.16%
on 04/09/25
Period Open: 5.22
6.16 -21.43%
on 02/14/25
-0.38 (-7.28%)
since 01/17/25
52-Week
3.05 +58.69%
on 04/25/24
Period Open: 7.93
8.17 -40.76%
on 04/18/24
-3.09 (-38.97%)
since 04/17/24

Most Recent Stories

More News
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO : 4.84 (-0.21%)
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans

ABEO : 4.84 (-0.21%)
Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference

ABEO : 4.84 (-0.21%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO : 4.84 (-0.21%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO : 4.84 (-0.21%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO : 4.84 (-0.21%)
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ABEO : 4.84 (-0.21%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

ESGH.TO : 28.34 (+1.61%)
THAR : 1.1299 (+2.72%)
ACXP : 0.3728 (-3.19%)
GRF.VN : 0.470 (unch)
WISA : 1.2100 (-6.92%)
ALCO : 29.45 (+1.83%)
NNVC : 1.3300 (-5.00%)
ABL : 8.15 (+1.62%)
MYPS : 1.2800 (-1.54%)
PERF : 1.6100 (-1.83%)
PETV : 0.5557 (+8.37%)
ABEO : 4.84 (-0.21%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

THAR : 1.1299 (+2.72%)
ACXP : 0.3728 (-3.19%)
UBI.AX : 0.061 (-1.61%)
GRF.VN : 0.470 (unch)
WISA : 1.2100 (-6.92%)
NNVC : 1.3300 (-5.00%)
ALCO : 29.45 (+1.83%)
MYPS : 1.2800 (-1.54%)
ABL : 8.15 (+1.62%)
PERF : 1.6100 (-1.83%)
PETV : 0.5557 (+8.37%)
ABEO : 4.84 (-0.21%)
Abeona Therapeutics' BLA Resubmission for Pz-Cel in RDEB Accepted by FDA, PDUFA Date Set for April 29, 2025

FDA accepted Abeona's BLA resubmission for pz-cel, setting a target action date of April 29, 2025.Quiver AI SummaryAbeona Therapeutics Inc. announced that the FDA has accepted its resubmission of the Biologics...

ABEO : 4.84 (-0.21%)

Business Summary

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

See More

Key Turning Points

3rd Resistance Point 5.07
2nd Resistance Point 5.01
1st Resistance Point 4.93
Last Price 4.84
1st Support Level 4.79
2nd Support Level 4.73
3rd Support Level 4.65

See More

52-Week High 8.17
Fibonacci 61.8% 6.21
Fibonacci 50% 5.61
Fibonacci 38.2% 5.01
Last Price 4.84
52-Week Low 3.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro